C.M. Bidwell & Associates’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,946
| Closed | -$334K | – | 519 |
|
|
2024
Q2 | $334K | Sell |
2,946
-7
| -0.2% | -$794 | 0.22% | 78 |
|
|
2024
Q1 | $410K | Sell |
2,953
-6
| -0.2% | -$832 | 0.28% | 67 |
|
|
2023
Q4 | $367K | Buy |
2,959
+1,155
| +64% | +$143K | 0.27% | 72 |
|
|
2023
Q3 | $168K | Buy |
+1,804
| New | +$168K | 0.13% | 136 |
|
|
2019
Q2 | – | Sell |
-12,200
| Closed | -$363K | – | 408 |
|
|
2019
Q1 | $363K | Buy |
12,200
+10,620
| +672% | +$316K | 0.36% | 85 |
|
|
2018
Q4 | $47K | Hold |
1,580
| – | – | 0.05% | 246 |
|
|
2018
Q3 | $57K | Hold |
1,580
| – | – | 0.05% | 223 |
|
|
2018
Q2 | $38K | Hold |
1,580
| – | – | 0.04% | 263 |
|
|
2018
Q1 | $29K | Hold |
1,580
| – | – | 0.03% | 269 |
|
|
2017
Q4 | $23K | Buy |
+1,580
| New | +$23K | 0.02% | 284 |
|
|
2015
Q2 | – | Sell |
-11,100
| Closed | -$173K | – | 233 |
|
|
2015
Q1 | $173K | Buy |
+11,100
| New | +$173K | 0.04% | 175 |
|